Total Payments
$1,067
2023 Payments
$42.36
Companies
7
Transactions
34
Payment Breakdown by Category
Food & Beverage$1,067 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,067 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $601.25 | 16 | $0 (2022) |
| ABBVIE INC. | $179.55 | 8 | $0 (2023) |
| Galderma Laboratories, L.P. | $163.62 | 3 | $0 (2023) |
| Lilly USA, LLC | $49.59 | 3 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $35.76 | 2 | $0 (2021) |
| PFIZER INC. | $19.98 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $17.15 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $42.36 | 2 | Galderma Laboratories, L.P. ($24.37) |
| 2022 | $575.88 | 17 | Allergan, Inc. ($518.64) |
| 2021 | $448.66 | 15 | Galderma Laboratories, L.P. ($139.25) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/30/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $24.37 | General |
| 01/29/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.99 | General |
| 11/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $41.58 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/13/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $34.02 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/13/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $23.62 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/12/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $41.58 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/12/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $34.02 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/12/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $23.62 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/01/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/01/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $34.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/01/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $32.61 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/01/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/30/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $59.25 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/30/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $49.72 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/30/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $39.06 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/30/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $23.44 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/30/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $13.26 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/12/2021 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.25 | General |
| 10/06/2021 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 09/09/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $82.61 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2021 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: NEUROSCIENCE | ||||||
About Crystal Trigger, PA-C
Crystal Trigger, PA-C is a Medical healthcare provider based in Moorpark, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1598152779.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Crystal Trigger, PA-C has received a total of $1,067 in payments from pharmaceutical and medical device companies, with $42.36 received in 2023. These payments were reported across 34 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,067).
Ad
Practice Information
- Specialty Medical
- Location Moorpark, CA
- Active Since 04/24/2015
- Last Updated 02/24/2020
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1598152779
Products in Payments
- BOTOX (Biological) $601.25
- VRAYLAR (Drug) $69.36
- QULIPTA (Drug) $57.24
- TRULICITY (Drug) $37.95
- TRINTELLIX (Drug) $35.76
- UBRELVY (Drug) $34.96
- COLOGUARD DNA CAPTURE REAGENTS (Device) $19.98
- AIMOVIG (Biological) $17.15
- EMGALITY (Drug) $11.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.